Cecile G. Dagohoy

5.3k total citations · 1 hit paper
14 papers, 3.9k citations indexed

About

Cecile G. Dagohoy is a scholar working on Epidemiology, Neurology and Oncology. According to data from OpenAlex, Cecile G. Dagohoy has authored 14 papers receiving a total of 3.9k indexed citations (citations by other indexed papers that have themselves been cited), including 11 papers in Epidemiology, 9 papers in Neurology and 9 papers in Oncology. Recurrent topics in Cecile G. Dagohoy's work include Neuroendocrine Tumor Research Advances (10 papers), Neuroblastoma Research and Treatments (8 papers) and Lung Cancer Research Studies (7 papers). Cecile G. Dagohoy is often cited by papers focused on Neuroendocrine Tumor Research Advances (10 papers), Neuroblastoma Research and Treatments (8 papers) and Lung Cancer Research Studies (7 papers). Cecile G. Dagohoy collaborates with scholars based in United States, United Kingdom and Australia. Cecile G. Dagohoy's co-authors include James C. Yao, Alexandria T. Phan, Colleen Leary, Manal M. Hassan, Douglas B. Evans, Asif Rashid, Jeannette E. Mares, Jason B. Fleming, Jean‐Nicolas Vauthey and Eddie K. Abdalla and has published in prestigious journals such as Journal of Clinical Oncology, International Journal of Cancer and Annals of Surgical Oncology.

In The Last Decade

Cecile G. Dagohoy

14 papers receiving 3.8k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

One Hundred Years After “Carcinoid”: Epidemiology of and Prognostic Factors for Neuroendocrine Tumors in 35,825 Cases in the United States

2008 3.3k citations James C. Yao, Manal M. Hassan et al. Journal of Clinical Oncology profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Cecile G. Dagohoy United States	8	3.6k	3.4k	2.4k	255	189	14	3.9k
Colleen Leary United States	8	3.8k 1.0×	3.4k 1.0×	2.5k 1.1×	272 1.1×	193 1.0×	11	4.0k
Jeannette E. Mares United States	7	3.6k 1.0×	3.3k 1.0×	2.4k 1.0×	238 0.9×	203 1.1×	13	3.9k
Christos Toumpanakis United Kingdom	36	4.1k 1.1×	3.6k 1.1×	2.9k 1.2×	591 2.3×	128 0.7×	158	4.7k
Klaus‐Jochen Klose Germany	11	2.0k 0.5×	1.8k 0.5×	1.5k 0.6×	176 0.7×	71 0.4×	18	2.3k
Behnaz Aminossadati Germany	7	2.1k 0.6×	1.9k 0.6×	1.6k 0.7×	124 0.5×	63 0.3×	9	2.3k
Anthony Chan United Kingdom	11	1.5k 0.4×	1.5k 0.4×	887 0.4×	183 0.7×	84 0.4×	22	1.7k
Letizia Boninsegna Italy	25	2.3k 0.6×	2.3k 0.7×	1.4k 0.6×	219 0.9×	34 0.2×	31	2.5k
Michelle Kang Kim United States	17	965 0.3×	1.0k 0.3×	515 0.2×	203 0.8×	53 0.3×	54	1.3k
Michael Böhmig Germany	15	838 0.2×	987 0.3×	588 0.2×	172 0.7×	29 0.2×	23	1.4k
Laura Schirosi Italy	15	210 0.1×	349 0.1×	151 0.1×	85 0.3×	55 0.3×	30	755

Countries citing papers authored by Cecile G. Dagohoy

Since Specialization

Citations

This map shows the geographic impact of Cecile G. Dagohoy's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Cecile G. Dagohoy with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Cecile G. Dagohoy more than expected).

Fields of papers citing papers by Cecile G. Dagohoy

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Cecile G. Dagohoy. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Cecile G. Dagohoy. The network helps show where Cecile G. Dagohoy may publish in the future.

Co-authorship network of co-authors of Cecile G. Dagohoy

This figure shows the co-authorship network connecting the top 25 collaborators of Cecile G. Dagohoy. A scholar is included among the top collaborators of Cecile G. Dagohoy based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Cecile G. Dagohoy. Cecile G. Dagohoy is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

14 of 14 papers shown

Rogers, Jane E., Michael Lam, Daniel M. Halperin, et al.. (2021). Fluorouracil, Doxorubicin with Streptozocin and Subsequent Therapies in Pancreatic Neuroendocrine Tumors. Neuroendocrinology. 112(1). 34–42. 12 indexed citations

Dasari, Arvind, Emily K. Bergsland, Al B. Benson, et al.. (2019). Treatment Patterns and Clinical Outcomes in Advanced Lung Neuroendocrine Tumors in Real-World Settings: A Multicenter Retrospective Chart Review Study. The Oncologist. 24(8). 1066–1075. 10 indexed citations

Halperin, Daniel M., J. Jack Lee, Chaan S. Ng, et al.. (2019). A Phase II Trial of Ziv-Aflibercept in Patients With Advanced Pancreatic Neuroendocrine Tumors. Pancreas. 48(3). 381–386. 7 indexed citations

Kulke, Matthew H., Al B. Benson, Arvind Dasari, et al.. (2019). Real-World Treatment Patterns and Clinical Outcomes in Advanced Gastrointestinal Neuroendocrine Tumors (GI NET): A Multicenter Retrospective Chart Review Study. The Oncologist. 24(8). 1056–1065. 7 indexed citations

Halperin, Daniel M., J. Jack Lee, Cecile G. Dagohoy, & James C. Yao. (2015). Rational Clinical Experiment: Assessing Prior Probability and Its Impact on the Success of Phase II Clinical Trials. Journal of Clinical Oncology. 33(26). 2914–2919. 3 indexed citations

Yao, James C., Alexandria T. Phan, Kenneth R. Hess, et al.. (2014). Perfusion Computed Tomography as Functional Biomarker in Randomized Run-In Study of Bevacizumab and Everolimus in Well-Differentiated Neuroendocrine Tumors. Pancreas. 44(2). 190–197. 42 indexed citations

Mares, Jeannette E., et al.. (2013). Improving the Success Rate of Gluteal Intramuscular Injections. Pancreas. 42(5). 878–882. 57 indexed citations

Leary, Colleen, et al.. (2010). Gluteal Intramuscular Injections. Pancreas. 39(2). 271–272. 1 indexed citations

Dagohoy, Cecile G., et al.. (2010). Gender Related Issues in Gluteal Intramuscular Injections. Pancreas. 39(2). 273–273. 2 indexed citations

10.

Hassan, Manal M., Alexandria T. Phan, Donghui Li, et al.. (2008). Family History of Cancer and Associated Risk of Developing Neuroendocrine Tumors: A Case-Control Study. Cancer Epidemiology Biomarkers & Prevention. 17(4). 959–965. 38 indexed citations

11.

Hassan, Manal M., Alexandria T. Phan, Donghui Li, et al.. (2008). Risk factors associated with neuroendocrine tumors: A U.S.‐based case–control study. International Journal of Cancer. 123(4). 867–873. 161 indexed citations

12.

Yao, James C., Manal M. Hassan, Alexandria T. Phan, et al.. (2008). One Hundred Years After “Carcinoid”: Epidemiology of and Prognostic Factors for Neuroendocrine Tumors in 35,825 Cases in the United States. Journal of Clinical Oncology. 26(18). 3063–3072. 3260 indexed citations breakdown →

13.

Yao, James C., Milton P. Eisner, Colleen Leary, et al.. (2007). Population-Based Study of Islet Cell Carcinoma. Annals of Surgical Oncology. 14(12). 3492–3500. 245 indexed citations

14.

Mares, Jeannette E., Milton P. Eisner, Cecile G. Dagohoy, et al.. (2007). Population based study of islet cell carcinoma. Journal of Clinical Oncology. 25(18_suppl). 15103–15103. 6 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact